INOVIO PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Inovio Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2013 to Q3 2024.
  • Inovio Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 28.1M shares, a 25.7% increase year-over-year.
  • Inovio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 22.2M shares, a 11.5% increase from 2022.
  • Inovio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 19.9M shares, a 14.3% increase from 2021.
  • Inovio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 17.4M shares, a 88.8% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 28.1M +5.76M +25.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 27.2M +5.17M +23.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 23.3M +1.76M +8.15% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 22.2M +2.29M +11.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 22.4M -227M -91% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 22M -213M -90.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 21.5M -197M -90.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 19.9M +2.48M +14.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 249M +39M +18.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 235M +25.7M +12.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 219M +16.5M +8.17% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 17.4M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 210M +44.9M +27.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 210M +53.8M +34.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 202M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 165M +66.3M +67% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 156M +57.7M +58.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q3 2019 99M +6.58M +7.13% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 98.1M +6.93M +7.6% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q4 2018 92.5M +10.8M +13.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 92.4M +5.47M +6.29% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 91.2M +15.7M +20.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 90.5M +16.3M +22% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-09
Q4 2017 81.8M +8.56M +11.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 87M +13.3M +18.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 75.4M +2.45M +3.36% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 74.2M +1.92M +2.66% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 73.2M +1.02M +1.41% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 73.6M +1.57M +2.18% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 73M +5.3M +7.84% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-08
Q1 2016 72.2M +11.5M +18.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 72.2M +11.6M +19.1% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-14
Q3 2015 72M +11.6M +19.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 67.7M +7.42M +12.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 60.7M +5.58M +10.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 60.6M +8.48M +16.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 60.4M +12.4M +25.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 60.2M +15.2M +33.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 55.2M +16.1M +41.3% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 52.1M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 48M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 45M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 39M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.